In this study, we identified the cell membrane protein intercellular adhesion molecule-1 (ICAM1) as a potential molecular therapeutic target for CCA by screening a panel of cancer-associated surface antigens in combination with clinical data. This evidence concerns the gene ICAM1 and cancer.